Skip to content
TrialScanner

NCT03168256

CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

Phase 3CompletedCANFLead

Registry record

Lead sponsor
Can-Fite BioPharma
Conditions
Plaque Psoriasis
Primary completion
Jan 6, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03168256 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03168256: CF101 Therapy in Patients... | TrialScanner